Piscataway, United States
GenScript, a key player in the Biotechnology sector, is headquartered in the United States and operates under the mission of "Scripting Possibilities - Make People and Nature Healthier through Biotechnology." Established in 2002, the company has become instrumental in advancing biotech and healthcare innovations. It achieves this by offering foundational support to researchers and companies working on groundbreaking treatments and products.
With approximately 6,165 employees, GenScript collaborates with a robust network of partners, spanning academic institutions and industry giants, including the world's Top 20 pharmaceutical companies. It serves a vast customer base of over 200,000 across 100+ countries and regions.
Recently, GenScript secured a substantial HKD2.33B post-IPO equity investment in a round dated 01 September 2026, highlighting continued investor confidence. This financial influx is pivotal for further scaling and spearheading innovation, cementing its role as a trusted global partner in the life sciences.
